Risk assessment as a guide for the prevention of cancer-associated thromboembolism.

Risk assessment as a guide for the prevention of cancer-associated thromboembolism. Int Angiol. 2018 Apr 11;: Authors: Al-Ogaili A, Fuentes HE, Tafur AJ, Caprini J Abstract Venous thromboembolism (VTE) is a major source of morbidity and mortality among patients diagnosed with cancer. In addition to an increased risk of VTE, patients with cancer are at higher risk of bleeding while receiving therapeutic anticoagulation. Aggressive and targeted thromboprophylaxis is a crucial practice to avoid the dreaded complications of VTE. Risk assessment models (RAM) are tools developed to identify high-risk patients in whom thromboprophylaxis is beneficial. This review describes the most validated VTE RAMs in patients with cancer. PMID: 29644835 [PubMed - as supplied by publisher]
Source: International Angiology - Category: Cardiology Tags: Int Angiol Source Type: research